Hyderabad: The Nizam Institute of Medical Sciences(NIMS), has been put behind, with the Medical Council Of India(MCI),denying it permission to start two new postgraduate medical courses due to lack of infrastructure and trained faculty.
The MCI’s Postgraduate Medical Education Committee (PGMEC) during its Jan 30 meeting in Delhi, made it amply clear that NIMS a deemed university, does not meet the compliance criterion for starting the postgraduate MD (Emergency medicine) and MD (Immuno Haematology & Blood Transfusion) courses in the 2017-18 academic year. The applications filed by the college, for both the proposed PG courses have been returned .
“The compliance submitted by the college for starting the courses is not satisfactory. PGMEC decided to return the application to the central government recommending disapproval for starting of MD (Emergency Medicine) and MD (Immuno Haematology & Blood Transfusion) at Nizam’s Institute of Medical Sciences, Hyderabad,” the MCI mentioned in its minutes.
The MCI cited lack of trained faculty as the primary reason for denial of permission to start the courses. The PGMEC while going through the assessment report in August and subsequent compliance report of the college in December 2016, held that “none of the faculty have two years special training in Emergency Medicine”.
The PGMEC put aside the college claim that the faculty had acquired on the job training in the emergency medicine department, saying that it could not be equated with with a two-year training.
The MCI, on the other hand highlighted insufficient experience of six senior resident doctors in the field of MD (Emergency Medicine).
The Telangana Junior Doctors’ Association (TJUDA), members feel that the denial of permission does not signify the end of their efforts.
“Denial of permission to start a new course does not mean that it cannot be applied afresh after meeting the deficiencies pointed out by the MCI,” said Dr G Srinivas, President, TJUDA to the TOI.
Interestingly, the two courses are being offered by a few corporate hospitals in an informal setting, without MCI’s approval.